{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:10:11Z","timestamp":1783635011208,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Surgical Oncology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1007\/bf02524346","type":"journal-article","created":{"date-parts":[[2006,11,8]],"date-time":"2006-11-08T00:03:52Z","timestamp":1162944232000},"page":"52-58","source":"Crossref","is-referenced-by-count":17,"title":["The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers"],"prefix":"10.1007","volume":"11","author":[{"given":"Itzhak","family":"Pappo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Meirshon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Karni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nava","family":"Siegelmann-Danielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varda","family":"Stahl-Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Sandbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Halevy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02524346_CR1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3810\/pgm.2000.07.1159","volume":"108","author":"DR Morrisey","year":"2000","unstructured":"Morrisey DR, Kirchner JT. Management of the climacteric.Postgrad Med 2000;108:85\u2013100.","journal-title":"Postgrad Med"},{"key":"BF02524346_CR2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/oxfordjournals.aje.a009142","volume":"145","author":"KM Brett","year":"1997","unstructured":"Brett KM, Madans JH. Use of postmenopausal hormone-replacement therapy: estimates from a nationally representative cohort study,Am J Epidemiol 1997;145:536\u201344.","journal-title":"Am J Epidemiol"},{"key":"BF02524346_CR3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1471-0528.1997.tb11456.x","volume":"104","author":"T Moorhead","year":"1997","unstructured":"Moorhead T, Hannaford P, Warskyi M. Prevalence and characteristics associated with the use of hormone-replacement therapy in Brain.Br J Obstet Gynaecol 1997;104:290\u20137.","journal-title":"Br J Obstet Gynaecol"},{"key":"BF02524346_CR4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00042192-200209000-00008","volume":"9","author":"B Kaplan","year":"2002","unstructured":"Kaplan B, Aschkenazi-Steinberg S, Yogev Y, Nahum R, Sulkes J, Phisher M. Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause.Menopause 2002;9:354\u20139.","journal-title":"Menopause"},{"key":"BF02524346_CR5","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJM197512042932302","volume":"293","author":"DC Smith","year":"1975","unstructured":"Smith DC, Prentice R, Thompson DJ, Hermann WL. Association of exogenous estrogen and endometrial cancer.N Engl J Med 1975;293:1164\u20137.","journal-title":"N Engl J Med"},{"key":"BF02524346_CR6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1470-2045(02)00732-5","volume":"3","author":"J Marsden","year":"2002","unstructured":"Marsden J. Hormone replacement therapy and breast cancer.Lancet Oncol 2002;3:303\u201311.","journal-title":"Lancet Oncol"},{"key":"BF02524346_CR7","first-page":"400","volume":"80","author":"DM Strickland","year":"1992","unstructured":"Strickland DM, Gambrell RD Jr, Butzin CA, Strickland K. The relationship between breast cancer survival and prior postmenopausal estrogen use.Obstet Gynecol 1992;80:400\u20134.","journal-title":"Obstet Gynecol"},{"key":"BF02524346_CR8","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/oxfordjournals.aje.a116042","volume":"134","author":"JR Palmer","year":"1991","unstructured":"Palmer JR, Rosenberg L, Clake EA, Miller DR, Shapiro S. Breast cancer risk after estrogen replacement therapy: Results from the Toronto breast cancer study.Am J Epidemiol 1991;134:1386\u201395.","journal-title":"Am J Epidemiol"},{"key":"BF02524346_CR9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/bjc.1995.310","volume":"72","author":"C Vecchia La","year":"1995","unstructured":"La Vecchia C, Negri E, Franceschi S, et al. Hormone replacement treatment and breast cancer risk: a cooperative Italian study.Br J Cancer 1995;72:244\u20138.","journal-title":"Br J Cancer"},{"key":"BF02524346_CR10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.aje.a117717","volume":"142","author":"PA Newcomb","year":"1995","unstructured":"Newcomb PA, Longnecker MP, Storer BE, et al. Long-term hormone replacement therapy and the risk of breast cancer in postmenopausal women.Am J Epidemiol 1995;142:788\u201395.","journal-title":"Am J Epidemiol"},{"key":"BF02524346_CR11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7326\/0003-4819-127-11-199712010-00004","volume":"127","author":"TA Sellers","year":"1997","unstructured":"Sellers TA, Mink PJ, Cerhan JR, et al. The role of hormone replacement therapy in the risk of breast cancer and total mortality in women with a family history of breast cancer.Ann Intern Med 1997;127:973\u201380.","journal-title":"Ann Intern Med"},{"key":"BF02524346_CR12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors for Breast Cancer","year":"1997","unstructured":"Collaborative Group on Hormonal Factors for Breast Cancer. Breast cancer and hormone replacement therapy. Collaborative reanalysis from 51 individual epidemiological studies.Lancet 1997;350:1047\u201360.","journal-title":"Lancet"},{"key":"BF02524346_CR13","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","volume":"332","author":"GA Colditz","year":"1995","unstructured":"Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.N Engl J Med 1995;332:1589\u201393.","journal-title":"N Engl J Med"},{"key":"BF02524346_CR14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","volume":"283","author":"C Schairer","year":"2000","unstructured":"Schairer C, Lubin J, Troisi R, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.JAMA 2000;283:485\u201391.","journal-title":"JAMA"},{"key":"BF02524346_CR15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","unstructured":"Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial.JAMA 2002;288:321\u201333.","journal-title":"JAMA"},{"key":"BF02524346_CR16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.287.6.734","volume":"287","author":"CL Chen","year":"2002","unstructured":"Chen CL, Weiss NS, Newcomb P, Barlow W, White E. Hormone replacement therapy in relation to breast cancer.JAMA 2002;287:734\u201341.","journal-title":"JAMA"},{"key":"BF02524346_CR17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00052671","volume":"7","author":"DB Willis","year":"1996","unstructured":"Willis DB, Calle EE, Miracle McMahil H, Heath CW. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States.Cancer Causes Control 1996;7:449\u201357.","journal-title":"Cancer Causes Control"},{"key":"BF02524346_CR18","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/bmj.312.7047.1646","volume":"312","author":"C Harding","year":"1996","unstructured":"Harding C, Knox WF, Faragher EB, Baildam A, Bundred NJ. Hormone replacement therapy and tumor grade in breast cancer: prospective study in screening unit.BMJ 1996;312:1646\u20137.","journal-title":"BMJ"},{"key":"BF02524346_CR19","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1200\/JCO.1998.16.9.3115","volume":"16","author":"K Holli","year":"1998","unstructured":"Holli K, Isola J, Cuzik, J. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy.J Clin Oncol 1998;16:3115\u201320.","journal-title":"J Clin Oncol"},{"key":"BF02524346_CR20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/BF02573064","volume":"9","author":"V Sacchini","year":"2002","unstructured":"Sacchini V, Zurrida S, Andreoni G, et al. Pathologic and biological prognostic factors in short- and long-term hormone replacement therapy users.Ann Surg Oncol 2002;9:266\u201371.","journal-title":"Ann Surg Oncol"},{"key":"BF02524346_CR21","volume-title":"Tumors of the Mammary Gland","author":"PP Rosen","year":"1993","unstructured":"Rosen PP, Oberman HA.Tumors of the Mammary Gland. Washington, DC: Armed Forces Institute of Pathology, 1993."},{"key":"BF02524346_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4757-3656-4","volume-title":"AJCC Cancer Staging Manual","author":"FL Green","year":"2002","unstructured":"Green FL, Page DL, Fleming ID, et al. The breast. In:AJCC Cancer Staging Manual. 6th ed. Heidelberg: Springer-Verlag, 2002:221\u201340.","edition":"6th ed."},{"key":"BF02524346_CR23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: the value of histological grade in breast cancer.Histopathology 1991;19:403\u201310.","journal-title":"Histopathology"},{"key":"BF02524346_CR24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/archsurg.137.9.1015","volume":"137","author":"J Cheek","year":"2002","unstructured":"Cheek J, Lacy J, Toth-Fejel S, Morris K, Calhoun C, Pommier R. The impact of hormone replacement therapy on the detection and stage of breast cancer.Arch Surg 2002;137:1015\u201321.","journal-title":"Arch Surg"},{"key":"BF02524346_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0378-5122(00)00213-9","volume":"38","author":"RC Delgado","year":"2001","unstructured":"Delgado RC, Lopez DML. Prognosis of breast cancer detected in women receiving hormone replacement therapy.Maturitas 2001; 38:147\u201356.","journal-title":"Maturitas"},{"key":"BF02524346_CR26","first-page":"513","volume":"95","author":"C Gajdos","year":"2000","unstructured":"Gajdos C, Tartter P, Babinzki A. Breast cancer diagnosed during hormone replacement therapy.Obstet Gynecol 2000;95:513\u20138.","journal-title":"Obstet Gynecol"},{"key":"BF02524346_CR27","first-page":"671","volume":"4","author":"D Merom","year":"2002","unstructured":"Merom D, Ifrah A, Cohen-Manheim I, Chinich A, Green MS. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel: the National Women's Health Interview Survey, 1998.IMAJ 2002;4:671\u20136.","journal-title":"IMAJ"},{"key":"BF02524346_CR28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1097-0215(199806)79:3<278::AID-IJC12>3.0.CO;2-5","volume":"79","author":"P Bonnier","year":"1998","unstructured":"Bonnier P, Bessenay F, Sasco AJ, et al. Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast Cancer.Int J Cancer 1998;79:278\u201382.","journal-title":"Int J Cancer"},{"key":"BF02524346_CR29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01806152","volume":"38","author":"C Magnusson","year":"1996","unstructured":"Magnusson C, Holmberg L, Norden T, Lindgren A, Persson I. Prognostic characteristics in breast cancers after hormone replacement therapy.Breast Cancer Res Treat 1996;38:325\u201334.","journal-title":"Breast Cancer Res Treat"},{"key":"BF02524346_CR30","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O","volume":"88","author":"CI Li","year":"2000","unstructured":"Li CI, Weiss NS, Stanford JL, Daling JR. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.Cancer 2000;88:2570\u20137.","journal-title":"Cancer"},{"key":"BF02524346_CR31","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/cncr.10984","volume":"95","author":"JR Daling","year":"2002","unstructured":"Daling JR, Malone KE, Doody DR, et al. Relation of reginens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.Cancer 2002;95:2455\u201364.","journal-title":"Cancer"},{"key":"BF02524346_CR32","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1001\/jama.281.22.2091","volume":"281","author":"SM Gapstur","year":"1999","unstructured":"Gapstur SM, Morrow M, Sellers TA. Hormone replacement therapy and the risk of breast cancer with a favorable histology.JAMA 1999;281:2091\u20137.","journal-title":"JAMA"},{"key":"BF02524346_CR33","first-page":"4669","volume":"37","author":"WA Knight","year":"1977","unstructured":"Knight WA, Livingstone RB, Gregory EJ, McGuire WL. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.Cancer Res 1977;37:4669\u201371.","journal-title":"Cancer Res"},{"key":"BF02524346_CR34","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s10434-001-0828-4","volume":"8","author":"GN Peters","year":"2001","unstructured":"Peters GN, Fodera T, Sabol J, Jones S, Euhus D. Estrogen replacement therapy after breast cancer: a 12-year follow-up.Ann Surg Oncol 2001;8:828\u201332.","journal-title":"Ann Surg Oncol"},{"key":"BF02524346_CR35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/bcr318","volume":"3","author":"JS Lawson","year":"2001","unstructured":"Lawson JS, Field AS, Tran DD, Houssami N. Hormone replacement therapy use dramatically increases breast oestrogen receptor expression in obese postmenopausal women.Breast Cancer Res 2001;3:342\u20135.","journal-title":"Breast Cancer Res"},{"key":"BF02524346_CR36","first-page":"5357","volume":"54","author":"CJ Fabian","year":"1994","unstructured":"Fabian CJ, Kimler BF, McKittrick R, et al. Recruitment with high physiological doses of estradiol preceding chemotherapy: flow cytometric and therapeutic results in women with locally advanced breast cancers\u2014a Southwest Oncology Group study.Cancer Res 1994;54:5357\u201362.","journal-title":"Cancer Res"},{"key":"BF02524346_CR37","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jama.281.16.1528","volume":"281","author":"MA Cobleigh","year":"1999","unstructured":"Cobleigh MA, Norlock FE, Oleske DM, Starr A. Hormone replacement therapy and high S phase in breast cancer.JAMA 1999;281:1528\u201330.","journal-title":"JAMA"},{"key":"BF02524346_CR38","first-page":"165","volume":"1198","author":"NE Hynes","year":"1994","unstructured":"Hynes NE, Stern DF. The biology of ErbB-2\/neu\/HER-2 and its role in cancer.Biochim Biophys Acta 1994;1198:165\u201384.","journal-title":"Biochim Biophys Acta"},{"key":"BF02524346_CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00666179","volume":"29","author":"SA Chrysogelos","year":"1994","unstructured":"Chrysogelos SA, Dickson RB. EGF receptor expression, regulation and function in breast cancer.Breast Cancer Res Treat 1994;29:29\u201340.","journal-title":"Breast Cancer Res Treat"},{"key":"BF02524346_CR40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1067\/mob.2002.121077","volume":"186","author":"K Nanda","year":"2002","unstructured":"Nanda K, Bastian LA, Schultz K. Hormone replacement therapy and the risk of death from breast cancer: a systematic review.Am J Obstet Gynecol 2002;186:325\u201334.","journal-title":"Am J Obstet Gynecol"},{"key":"BF02524346_CR41","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199706193362501","volume":"336","author":"F Grodstein","year":"1997","unstructured":"Grodstein F, Stampfer MJ, Colditz G, et al. Postmenopausal hormone therapy and mortality.N Engl J Med 1997;336:1769\u201376.","journal-title":"N Engl J Med"},{"key":"BF02524346_CR42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1200\/JCO.2002.20.3.699","volume":"20","author":"G Ursin","year":"2002","unstructured":"Ursin G, Tseng CC, Paganini-Hill, et al. Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?J Clin Oncol 2002;20:699\u2013706.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02524346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02524346\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02524346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T16:42:11Z","timestamp":1558284131000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02524346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["BF02524346"],"URL":"https:\/\/doi.org\/10.1007\/bf02524346","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}